Cargando…

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

INTRODUCTION: Given the continuing COVID-19 pandemic and much of the U.S. implementing social distancing owing to the lack of alternatives, there has been a push to develop a vaccine to eliminate the need for social distancing. METHODS: In 2020, the team developed a computational model of the U.S. s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Sarah M., O'Shea, Kelly J., Ferguson, Marie C., Bottazzi, Maria Elena, Wedlock, Patrick T., Strych, Ulrich, McKinnell, James A., Siegmund, Sheryl S., Cox, Sarah N., Hotez, Peter J., Lee, Bruce Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal of Preventive Medicine. Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361120/
https://www.ncbi.nlm.nih.gov/pubmed/32778354
http://dx.doi.org/10.1016/j.amepre.2020.06.011
_version_ 1783559347618447360
author Bartsch, Sarah M.
O'Shea, Kelly J.
Ferguson, Marie C.
Bottazzi, Maria Elena
Wedlock, Patrick T.
Strych, Ulrich
McKinnell, James A.
Siegmund, Sheryl S.
Cox, Sarah N.
Hotez, Peter J.
Lee, Bruce Y.
author_facet Bartsch, Sarah M.
O'Shea, Kelly J.
Ferguson, Marie C.
Bottazzi, Maria Elena
Wedlock, Patrick T.
Strych, Ulrich
McKinnell, James A.
Siegmund, Sheryl S.
Cox, Sarah N.
Hotez, Peter J.
Lee, Bruce Y.
author_sort Bartsch, Sarah M.
collection PubMed
description INTRODUCTION: Given the continuing COVID-19 pandemic and much of the U.S. implementing social distancing owing to the lack of alternatives, there has been a push to develop a vaccine to eliminate the need for social distancing. METHODS: In 2020, the team developed a computational model of the U.S. simulating the spread of COVID-19 coronavirus and vaccination. RESULTS: Simulation experiments revealed that to prevent an epidemic (reduce the peak by >99%), the vaccine efficacy has to be at least 60% when vaccination coverage is 100% (reproduction number=2.5–3.5). This vaccine efficacy threshold rises to 70% when coverage drops to 75% and up to 80% when coverage drops to 60% when reproduction number is 2.5, rising to 80% when coverage drops to 75% when the reproduction number is 3.5. To extinguish an ongoing epidemic, the vaccine efficacy has to be at least 60% when coverage is 100% and at least 80% when coverage drops to 75% to reduce the peak by 85%–86%, 61%–62%, and 32% when vaccination occurs after 5%, 15%, and 30% of the population, respectively, have already been exposed to COVID-19 coronavirus. A vaccine with an efficacy between 60% and 80% could still obviate the need for other measures under certain circumstances such as much higher, and in some cases, potentially unachievable, vaccination coverages. CONCLUSIONS: This study found that the vaccine has to have an efficacy of at least 70% to prevent an epidemic and of at least 80% to largely extinguish an epidemic without any other measures (e.g., social distancing).
format Online
Article
Text
id pubmed-7361120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Journal of Preventive Medicine. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73611202020-07-15 Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention Bartsch, Sarah M. O'Shea, Kelly J. Ferguson, Marie C. Bottazzi, Maria Elena Wedlock, Patrick T. Strych, Ulrich McKinnell, James A. Siegmund, Sheryl S. Cox, Sarah N. Hotez, Peter J. Lee, Bruce Y. Am J Prev Med Research Article INTRODUCTION: Given the continuing COVID-19 pandemic and much of the U.S. implementing social distancing owing to the lack of alternatives, there has been a push to develop a vaccine to eliminate the need for social distancing. METHODS: In 2020, the team developed a computational model of the U.S. simulating the spread of COVID-19 coronavirus and vaccination. RESULTS: Simulation experiments revealed that to prevent an epidemic (reduce the peak by >99%), the vaccine efficacy has to be at least 60% when vaccination coverage is 100% (reproduction number=2.5–3.5). This vaccine efficacy threshold rises to 70% when coverage drops to 75% and up to 80% when coverage drops to 60% when reproduction number is 2.5, rising to 80% when coverage drops to 75% when the reproduction number is 3.5. To extinguish an ongoing epidemic, the vaccine efficacy has to be at least 60% when coverage is 100% and at least 80% when coverage drops to 75% to reduce the peak by 85%–86%, 61%–62%, and 32% when vaccination occurs after 5%, 15%, and 30% of the population, respectively, have already been exposed to COVID-19 coronavirus. A vaccine with an efficacy between 60% and 80% could still obviate the need for other measures under certain circumstances such as much higher, and in some cases, potentially unachievable, vaccination coverages. CONCLUSIONS: This study found that the vaccine has to have an efficacy of at least 70% to prevent an epidemic and of at least 80% to largely extinguish an epidemic without any other measures (e.g., social distancing). American Journal of Preventive Medicine. Published by Elsevier Inc. 2020-10 2020-07-15 /pmc/articles/PMC7361120/ /pubmed/32778354 http://dx.doi.org/10.1016/j.amepre.2020.06.011 Text en © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Article
Bartsch, Sarah M.
O'Shea, Kelly J.
Ferguson, Marie C.
Bottazzi, Maria Elena
Wedlock, Patrick T.
Strych, Ulrich
McKinnell, James A.
Siegmund, Sheryl S.
Cox, Sarah N.
Hotez, Peter J.
Lee, Bruce Y.
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title_full Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title_fullStr Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title_full_unstemmed Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title_short Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
title_sort vaccine efficacy needed for a covid-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361120/
https://www.ncbi.nlm.nih.gov/pubmed/32778354
http://dx.doi.org/10.1016/j.amepre.2020.06.011
work_keys_str_mv AT bartschsarahm vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT osheakellyj vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT fergusonmariec vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT bottazzimariaelena vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT wedlockpatrickt vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT strychulrich vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT mckinnelljamesa vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT siegmundsheryls vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT coxsarahn vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT hotezpeterj vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention
AT leebrucey vaccineefficacyneededforacovid19coronavirusvaccinetopreventorstopanepidemicasthesoleintervention